In the UK, we are one of the leading pharmaceutical suppliers1 in the UK retail market.
We are committed to improving access to high-quality medicines while working to ensure a reliable supply so patients can get the treatments they need, when and where they need them. Our portfolio, supported by our science, medical and manufacturing expertise, delivers global iconic and key brands, biosimilars, generics - including complex and branded generics - and over-the-counter products.
We produce medicines for patients across a broad range of major therapeutic areas, spanning both non-communicable and infectious diseases.
Easing the burden of non-communicable diseases:
According to the World Health Organization (WHO), non-communicable diseases (NCDs), such as ischemic heart disease, stroke, diabetes, certain cancers and chronic obstructive pulmonary disease, were among the leading causes of death globally as of 2016.2
Fighting infectious disease:
We are also a global leader3 in treating infectious diseases such as HIV/AIDS, hepatitis and tuberculosis, and offer an extensive portfolio across these disease states.
- IQVIA MIDAS December 2022, 2nd in volume, 1st in value
- World Health Organization. The top 10 causes of death, Available at: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death (Accessed: March 2023).
- Viatris 2021 Sustainability Report, page 23